L. L. Brunton, J. S. Lazo, L. Keith, J. P. Hannon, M. et al., Molecular, pharmacological and functional diversity of 5-HT receptors, Pharmacol Biochem Behav, vol.71, pp.297-316, 2002.

S. J. Warden, M. M. Bliziotes, K. M. Wiren, A. J. Eshleman, T. et al., Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine), Molecular and Cellular Endocrinology, vol.242, issue.1-2, pp.1-9, 2005.
DOI : 10.1016/j.mce.2005.06.005

M. M. Bliziotes, A. J. Eshleman, X. W. Zhang, and K. M. Wiren, Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake, Bone, vol.29, issue.5, pp.477-486, 2001.
DOI : 10.1016/S8756-3282(01)00593-2

S. J. Warden, A. G. Robling, M. S. Sanders, M. M. Bliziotes, T. et al., Inhibition of the Serotonin (5-Hydroxytryptamine) Transporter Reduces Bone Accrual during Growth, Endocrinology, vol.146, issue.2, pp.685-693, 2005.
DOI : 10.1210/en.2004-1259

I. Westbroek, A. Van-der-plas, K. E. De-rooij, J. Klein-nulend, and P. J. Nijweide, Expression of Serotonin Receptors in Bone, Journal of Biological Chemistry, vol.276, issue.31, pp.28961-28968, 2001.
DOI : 10.1074/jbc.M101824200

M. Bliziotes, A. Eshleman, B. Burt-pichat, X. W. Zhang, J. Hashimoto et al., Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells, Bone, vol.39, issue.6, pp.1313-1334, 2006.
DOI : 10.1016/j.bone.2006.06.009

B. I. Gustafsson, L. Thommesen, A. K. Stunes, K. Tommeras, I. Westbroek et al., Serotonin and fluoxetine modulate bone cell function in vitro, Journal of Cellular Biochemistry, vol.276, issue.1, pp.139-151, 2006.
DOI : 10.1002/jcb.20734

D. L. Shuey, T. W. Sadler, and J. M. Lauder, Serotonin as a regulator of craniofacial morphogenesis: Site specific malformations following exposure to serotonin uptake inhibitors, Teratology, vol.110, issue.4, pp.367-378, 1992.
DOI : 10.1002/tera.1420460407

J. R. Moiseiwitsch, The Role of Serotonin and Neurotransmitters During Craniofacial Development, Critical Reviews in Oral Biology & Medicine, vol.11, issue.2, pp.230-239, 2000.
DOI : 10.1177/10454411000110020601

D. S. Choi, S. J. Ward, N. Messaddeq, J. M. Launay, and L. Maroteaux, 5- HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells, Development, vol.124, pp.1745-1755, 1997.

M. Locker, J. Bitard, C. Collet, A. Poliard, V. Mutel et al., Stepwise control of osteogenic differentiation by 5-HT2B receptor signaling: Nitric oxide production and phospholipase A2 activation, Cellular Signalling, vol.18, issue.5, pp.628-639, 2006.
DOI : 10.1016/j.cellsig.2005.06.006
URL : https://hal.archives-ouvertes.fr/hal-00283605

J. M. Launay, G. Birraux, D. Bondoux, J. Callebert, D. S. Choi et al., Ras Involvement in Signal Transduction by the Serotonin 5-HT2B Receptor, Journal of Biological Chemistry, vol.271, issue.6, pp.3141-3147, 1996.
DOI : 10.1074/jbc.271.6.3141

C. G. Nebigil, D. S. Choi, A. Dierich, P. Hickel, L. Meur et al., Serotonin 2B receptor is required for heart development, Proceedings of the National Academy of Sciences, vol.97, issue.17, pp.9508-9513, 2000.
DOI : 10.1073/pnas.97.17.9508

D. Merciris, C. Marty, C. Collet, M. C. De-vernejoul, and V. Geoffroy, Overexpression of the Transcriptional Factor Runx2 in Osteoblasts Abolishes the Anabolic Effect of Parathyroid Hormone in Vivo, The American Journal of Pathology, vol.170, issue.5, pp.1676-1685, 2007.
DOI : 10.2353/ajpath.2007.061069

A. M. Parfitt, M. K. Drezner, F. H. Glorieux, J. A. Kanis, H. Malluche et al., Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee, Journal of Bone and Mineral Research, vol.10, issue.6, pp.595-610, 1987.
DOI : 10.1002/jbmr.5650020617

V. Geoffroy, C. Marty-morieux, L. Goupil, N. Clement-lacroix, P. Terraz et al., In Vivo Inhibition of Osteoblastic Metalloproteinases Leads to Increased Trabecular Bone Mass, Journal of Bone and Mineral Research, vol.8, issue.5, pp.811-822, 2004.
DOI : 10.1359/jbmr.040119

O. Kellermann, S. Loric, L. Maroteaux, and J. M. Launay, Sequential onset of three 5-HT receptors during the 5-hydroxytryptaminergic differentiation of the murine 1C11 cell line, British Journal of Pharmacology, vol.42, issue.5, pp.1161-1170, 1996.
DOI : 10.1111/j.1476-5381.1996.tb15519.x

T. L. Chen, Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment, Bone, vol.35, issue.1, pp.83-95, 2004.
DOI : 10.1016/j.bone.2004.03.019

R. Battaglino, J. Fu, U. Spate, U. Ersoy, M. Joe et al., Serotonin Regulates Osteoclast Differentiation Through Its Transporter, Journal of Bone and Mineral Research, vol.157, issue.9, pp.1420-1431, 2004.
DOI : 10.1359/JBMR.040606

A. M. Parfitt, A. R. Villanueva, J. Foldes, and D. S. Rao, Relations between histologic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis, Journal of Bone and Mineral Research, vol.327, issue.2, pp.466-473, 1995.
DOI : 10.1002/jbmr.5650100319

R. L. Jilka, R. S. Weinstein, K. Takahashi, A. M. Parfitt, and S. C. Manolagas, Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence., Journal of Clinical Investigation, vol.97, issue.7, pp.1732-1740, 1996.
DOI : 10.1172/JCI118600

N. Bhasin, E. Kernick, X. Luo, H. E. Seidel, E. R. Weiss et al., Differential regulation of chondrogenic differentiation by the serotonin2B receptor and retinoic acid in the embryonic mouse hindlimb, Developmental Dynamics, vol.272, issue.2, pp.201-209, 2004.
DOI : 10.1002/dvdy.20038

N. Bhasin, A. S. Lamantia, and J. M. Lauder, Opposing regulation of cell proliferation by retinoic acid and the serotonin 2B receptor in the mouse frontonasal mass, Anatomy and Embryology, vol.208, issue.2, pp.135-143, 2004.
DOI : 10.1007/s00429-004-0380-7

M. Bonyadi, S. D. Waldman, D. Liu, J. E. Aubin, M. D. Grynpas et al., Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice, Proceedings of the National Academy of Sciences, vol.100, issue.10, pp.5840-5845, 2003.
DOI : 10.1073/pnas.1036475100

K. Stenderup, J. Justesen, C. Clausen, and M. Kassem, Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells,, Bone, vol.33, issue.6, pp.919-926, 2003.
DOI : 10.1016/j.bone.2003.07.005

P. Meunier, J. Aaron, C. Edouard, and G. Vignon, Osteoporosis and the Replacement of Cell Populations of the Marrow by Adipose Tissue, Clinical Orthopaedics and Related Research, vol.80, pp.147-154, 1971.
DOI : 10.1097/00003086-197110000-00021

O. Kajkenova, B. Lecka-czernik, I. Gubrij, S. P. Hauser, K. Takahashi et al., Increased Adipogenesis and Myelopoiesis in the Bone Marrow of SAMP6, a Murine Model of Defective Osteoblastogenesis and Low Turnover Osteopenia, Journal of Bone and Mineral Research, vol.58, issue.S1, pp.1772-1779, 1997.
DOI : 10.1359/jbmr.1997.12.11.1772

M. Lesurtel, R. Graf, B. Aleil, D. J. Walther, Y. Tian et al., Platelet-Derived Serotonin Mediates Liver Regeneration, Science, vol.312, issue.5770, pp.104-107, 2006.
DOI : 10.1126/science.1123842

C. G. Nebigil, J. M. Launay, P. Hickel, C. Tournois, and L. Maroteaux, 5-Hydroxytryptamine 2B receptor regulates cell-cycle progression: Cross-talk with tyrosine kinase pathways, Proceedings of the National Academy of Sciences, vol.97, issue.6, pp.2591-2596, 2000.
DOI : 10.1073/pnas.050282397

S. L. Cheng, C. S. Shin, D. A. Towler, C. , and R. , A Dominant Negative Cadherin Inhibits Osteoblast Differentiation, Journal of Bone and Mineral Research, vol.242, issue.12, pp.2362-2370, 2000.
DOI : 10.1359/jbmr.2000.15.12.2362

C. S. Shin, F. Lecanda, S. Sheikh, L. Weitzmann, S. L. Cheng et al., Relative abundance of different cadherins defines differentiation of mesenchymal precursors into osteogenic, myogenic, or adipogenic pathways, Journal of Cellular Biochemistry, vol.49, issue.4, pp.566-577, 2000.
DOI : 10.1002/1097-4644(20000915)78:4<566::AID-JCB6>3.0.CO;2-K

M. Kubera, M. Maes, G. Kenis, Y. K. Kim, and W. Lason, Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor ?? and interleukin-6, Psychiatry Research, vol.134, issue.3, pp.251-258, 2005.
DOI : 10.1016/j.psychres.2004.01.014

F. Jaffre, J. Callebert, A. Sarre, N. Etienne, C. G. Nebigil et al., Involvement of the Serotonin 5-HT2B Receptor in Cardiac Hypertrophy Linked to Sympathetic Stimulation: Control of Interleukin-6, Interleukin-1??, and Tumor Necrosis Factor-?? Cytokine Production by Ventricular Fibroblasts, Circulation, vol.110, issue.8, pp.969-974, 2004.
DOI : 10.1161/01.CIR.0000139856.20505.57
URL : https://hal.archives-ouvertes.fr/hal-01274954

N. Franchimont, S. Wertz, and M. Malaise, Interleukin-6: An osteotropic factor influencing bone formation?, Bone, vol.37, issue.5, pp.601-606, 2005.
DOI : 10.1016/j.bone.2005.06.002

R. G. Ruddell, F. Oakley, Z. Hussain, I. Yeung, L. J. Bryan-lluka et al., A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis Characterization of the contractile 5- hydroxytryptamine receptor in the renal artery of the normotensive rat, Am J Pathol J Pharmacol Exp Ther, vol.169, issue.309, pp.861-876, 2004.

J. M. Launay, B. Schneider, S. Loric, M. Da-prada, and O. Kellermann, Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells, The FASEB Journal, vol.20, issue.11, pp.1843-1854, 2006.
DOI : 10.1096/fj.06-5724com

J. Callebert, J. M. Esteve, P. Herve, K. Peoc-'h, C. Tournois et al., Evidence for a Control of Plasma Serotonin Levels by 5-Hydroxytryptamine2B Receptors in Mice, Journal of Pharmacology and Experimental Therapeutics, vol.317, issue.2, pp.724-731, 2006.
DOI : 10.1124/jpet.105.098269
URL : https://hal.archives-ouvertes.fr/hal-01274937